If you are at #ESGCT23 join us today at our Symposium “Breaking down barriers bringing the benefits of gene therapy to patients” with Dr Luca D’Angelo and Prof Wuh-Liang (Paul) Hwu at 13:25-14:25 in Shed 2b #genetherapy#AADCdeficiency
Definitely agree that natural history studies help advance #raredisease treatments. They help patients, families, clinicians, regulators, payers, policy makers understand the disease and make informed decisions.
Learn more about natural history studies and why they are so important in the study of #rarediseases and development of potential therapies: https://t.co/MCkdeNGkM6
Here are a few reasons @_RafaelSierra is looking forward to moderating our sponsored symposium on #AADCdeficiency with Prof. Hwu, Dr. Chien and the Poulin family. Join us on August 5 in Bangkok, Thailand. #AOCCN2023#AADCd
Does your brother or sister have a #raredisease? Join us at 7 p.m. EDT tomorrow, July 26, as we spotlight your important role. This webinar will be held entirely in Spanish. To register, please visit: https://t.co/sG8PlkVsUk
Look forward to moderating @PTCBio’s #AADCdeficiency symposia at #AOCCN2023 in Bangkok. Unique opportunity to hear from Prof Hwu, Dr Chien and the Poulin Family of their #raredisease#AADCd experience.
Gain insights on diagnosis and the impact of #AADCdeficiency from experts and caregivers at our symposium on August 5 at the 16th Asian Oceanian Congress of Child Neurology (AOCCN). #AADCd#AOCCN2023
We’re proud to be featured in a recent article from @NatureBiotech. “Unprecedented blood biomarker enables ALS drug approval” includes PTC’s approach to #ALS, highlights the ongoing CARDINALS trial and shares insights from our CEO Dr. Matthew Klein.
It was great too see so many colleagues and friends today at the #EPNS2023 PTC #AADCdeficiency symposia. Great presentations from Prof F Ezgu, Prof T Opladen, and Dr H-M Lee. Focused on multidisciplinary teams working together to help kids with #raredisease#AADCdeficiency
Counting the days to #EPNS2023 to see my colleagues, investigators, and friends. I am proud of the scientific posters and activities our GMA team has put together to advance #raredisease#AADCdeficiency awareness.
We’re looking forward to #EPNS2023 to help advance research and knowledge of rare neurological conditions like #Duchenne muscular dystrophy, #AADCdeficiency and mitochondrial disease. PTC has a number of activities planned, including two symposia, two booths and numerous posters.
We’re looking forward to #EPNS2023 to help advance research and knowledge of rare neurological conditions like #Duchenne muscular dystrophy, #AADCdeficiency and mitochondrial disease. PTC has a number of activities planned, including two symposia, two booths and numerous posters.
We're honored to be selected as a finalist in the 2023 Prix Galien UK Award for "Best Pharmaceutical Product." We look forward to joining colleagues and other finalists at the award ceremony on May 11 in London. Read more: https://t.co/Afb5f8QEtR
We're honored to be selected as a finalist in the 2023 Prix Galien UK Award for "Best Pharmaceutical Product." We look forward to joining colleagues and other finalists at the award ceremony on May 11 in London. Read more: https://t.co/Afb5f8QEtR